No Detail Found!

Assessment of COVID-19 vaccine booster dose acceptance, reluctance and concerns among elderly diabetes patients in Pakistan

Author(s)
Lailoona Jaweed Department of Pharmacy, Iqra University,Karachi,Pakistan
Zeeshan Ahmed Department of Pharmacy, Iqra University,Karachi,Pakistan
Salman Ashfaq Ahmad Department of Pharmacy, Iqra University, Karachi, Pakistan;Department of Pharmaceutics, Faculty of Pharmacy and Pharmaceutical Sciences, University of Karachi, Karachi, Pakistan
Muhammad Imran Department of Pharmacy, Iqra University,Karachi,Pakistan
Saira Faraz Department of Pharmacognosy, Faculty of Pharmacy and Pharmaceutical Sciences, University of Karachi, Karachi, Pakistan;Department of Pharmacy, Nazeer Hussain University, Karachi, Pakistan
Tuba Sahar Department of Pharmaceutics, Faculty of Pharmacy and Pharmaceutical Sciences, University of Karachi, Karachi, Pakistan;Department of Pharmacy, Nazeer Hussain University, Karachi, Pakistan
Joohum Jaweed Department of Pharmaceutics, Faculty of Pharmacy and Pharmaceutical Sciences, University of Karachi,Karachi,Pakistan
Muhammad Bilal Maqsood Eastern Health cluster, Ministry of health,Dammam,Saudi Arabia
Salman Ahmed Department of Pharmacy, Iqra University, Karachi, Pakistan
Adnan Iqbal Department of Pharmacology, Faculty of Pharmacy and Pharmaceutical Sciences, University of Karachi,Karachi,Pakistan
Ammara Khalid Department of Pharmacy, Iqra University,Karachi,Pakistan
Shayan Ahmed Department of Pharmacy, Iqra University,Karachi,Pakistan
Azfar Athar Ishaqui Department of Pharmacy, Iqra University,Karachi,Pakistan
Abstract
People around the globe rumored so many things about the safety and efficacy of initial two doses and booster dose of Covid-19 vaccine, which eventually affected the acceptance of the only tool available against the fight between humans and virus. The aim of current study is to evaluate the acceptance and reluctance level among the population specifically elderly diabetes patients. The cross-sectional study was conducted during a time period of 3 months i.e. from July 2021 until September 2021. A 16-item questionnaire was used to assess the acceptance, reluctance, and concerns of the Covid-19 vaccine booster dose among elderly diabetes patients. A 16-item questionnaire was used to assess the acceptance, reluctance, and concerns of the Covid-19 vaccine booster dose among elderly diabetes patients. A total of 497 responses were collected and analyzed. Approximately 32% of respondents believed that they need additional information about the Covid-19 vaccine booster dose will be ineffective due to not enough information about the potential side effects of the vaccine dose, while around 80% of respondents showed concerns about safety, efficacy, newness and not enough information about vaccine contents. Around 47.1% of respondents expressed robust concerns about possible side effects of the Covid-19 vaccine booster dose. 
Publication Details
Page(s) 1269-1274
Published Journal: Pakistan Journal of Pharmaceutical Sciences, Volume: 35, Issue: S4, Year: 2022

Request the full text from PASTIC

Keywords
Booster dose, Elderly, COVID-19, diabetes., Vaccine
References
Al-Mulla R,Abu-Madi M,Talafha QM,Tayyem RF,Abdallah AM .2021 .COVID-19 vaccine hesitancy in a representative education sector population in Qatar. Vaccines, 9(6) : 665.
Aldossari KK,Alharbi MB,Alkahtani SM,Alrowaily TZ,Alshaikhi AM,Twair AA .2021 .COVID-19 vaccine hesitancy among patients with diabetes in Saudi Arabia. Diabetes & metabolic syndrome: Clin. Res. Rev, 15(5) : 102271.
Ataullahjan A,Ahsan H,Soofi S,Habib MA,Bhutta ZA .2021 .Eradicating polio in Pakistan: A systematic review of programs and policies. Expert Rev. Vaccines, 20(6) : 661-678.
Batra K,Sharma M,Dai CL,Khubchandani J .2022 .COVID-19 Booster Vaccination Hesitancy in the United States: A Multi-Theory-Model (MTM)-Based National Assessment. Vaccines, 10(5) : 758.
Biswas N,Mustapha T,Khubchandani J,Price JH .2021 .The nature and extent of COVID-19 vaccination hesitancy in healthcare workers. J. Community. Health, 46(6) : 1244-1251.
Bsoul EA,Loomer PM .2022 .COVID-19 vaccination experience among United States dental professionals and students: Safety, confidence, concerns, and side effects. PloS One, 17(2) : e0264323.
CDC .2021 .Risks and Vaccine Information for Older Adults. Center for Disease Control. , : .
Chou W-YS .2020 .Considering emotion in COVID-19 vaccine communication: Aaddressing vaccine hesitancy and fostering vaccine confidence. Health. Commun, 35(14) : 1718-1722.
DeRoo SS,Pudalov NJ,Fu LY .2020 .Planning for a COVID-19 vaccination program. JAMA., 323(24) : 2458-2459.
Dietz L,Horve PF,Coil DA,Fretz M,Eisen JA,Van Den Wymelenberg K .2020 .2019 novel coronavirus (COVID-19) pandemic: Built environment considerations to reduce transmission. Msystems, 5(2) : e00245-00220.
Jairoun AA,Al-Hemyari SS,El-Dahiyat F,Jairoun M,Shahwan M,Al Ani M,Habeb M,Babar Z-U-D M .2022 .Assessing public knowledge, attitudes and determinants of third COVID-19 vaccine booster dose acceptance: current scenario and future perspectives. J. Pharm. Policy Pract, 15(1) : 1-13.
Khan YH,Mallhi TH,Alotaibi NH,Alzarea AI,Alanazi AS,Tanveer N,Hashmi FK .2020 .Threat of COVID-19 vaccine hesitancy in Pakistan: The need for measures to neutralize misleading narratives. Am. J. Trop. Med, 103(2) : 603.
Maqsood MB,Islam MA,Al Qarni A,Ishaqui AA,Alharbi NK,Almukhamel M,Hossain MA,Fatani N,Mahrous AJ,Al Arab M AJ .2022 .Assessment of COVID-19 Vaccine Acceptance and Reluctance Among Staff Working in Public Healthcare Settings of Saudi Arabia: A Multicenter Study. Frontiers in Public Health, 10 : .
Maxmen A,Mallapaty S A .2021 .The COVID lab-leak hypothesis: What scientists do and don't know. Nature, 594(7863) : 313-315.
McSpadden J .2021 .Vaccine hesitancy among older adults, with implications for COVID-19 vaccination and beyond. , : .
Powers AC,Aronoff DM,Eckel RH DM .2021 .COVID19 vaccine prioritisation for type 1 and type 2 diabetes. Lancet. Diabetes. Endocrinol.. 9, (3) : 140-141.
Puig-Domingo M,Marazuela M,Giustina A .2020 .COVID-19 and endocrine diseases. A statement from the European Society of Endocrinology. , 68(1) : 2-5.
Raosoft I,Sacks LJ,Pham CT,Fleming N,Neoh SL,Ekinci EI .2020 .Considerations for people with diabetes during the coronavirus disease (COVID-19) pandemic. Diabetes Res. Clin. Pract, 166(1) : 108296.
Tokiya M,Hara M,Matsumoto A,Ashenagar MS,Nakano T,Hirota Y .2022 .Acceptance of booster COVID-19 caccine and its association with components of vaccination readiness in the general population: A cross-sectional survey for starting booster dose in Japan. , 10(7) : 1102.
Tung TH,Lin XQ,Chen Y,Zhang MX,Zhu JS .2022 .Willingness to receive a booster dose of inactivated coronavirus disease 2019 vaccine in Taizhou, China. Expert Rev. Vaccines., 21(2) : 261-267.
Wang Y,Duan L,Li M,Wang J,Yang J,Song C,Li J,Wang J,Jia J,Xu J .2022 .COVID-19 vaccine hesitancy and associated factors among diabetes patients: A cross-sectional survey in Changzhi, Shanxi, China. , 10(1) : 129.
Zarak MS,Sana H,Arshad Z,Saleem A,Shah M,Tareen H,Ullah S,Baloch SA,Kakar S SA .2022 .Understanding the reasons for refusal of polio vaccine by families in Quetta Block, Pakistan. , 28(7) : 498-505.
Zhu H,Wei L,Niu P .2020 .The novel coronavirus outbreak in Wuhan, China. G. Health. Res. Pol.. 5, (1) : 1-3.
0

Citations

0

Downloads

10

Views